Jynarque
Ended Awarded
- Contract number
- 36C26124N0679
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,581
Award facts
- Contract value 100% obligated
- $12,580.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at approximately $12.6K, awards Otsuka America Pharmaceutical Inc. the supply of JYNARQUE (tolvaptan) to the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21). The contract, awarded on May 23, 2024, with an ultimate completion date of August 23, 2024, operates under a firm fixed-price arrangement with no set-aside designation. The pharmaceutical product will be delivered to Potomac, Maryland, and falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), through which the VA procures specialized medications for its healthcare system.
This delivery order is issued against Otsuka America Pharmaceutical Inc.'s broader Blanket Purchase Agreement with the VA's National Acquisition Center, which carries a maximum value of approximately $83.3 million through March 26, 2026. JYNARQUE is a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. The company maintains significant federal contracting relationships with the VA across multiple Integrated Service Networks and holds an additional $396 million Federal Supply Schedule contract, positioning it as a key supplier of pharmaceutical and hematology products to the federal healthcare system. This arrangement enables efficient procurement of critical medications while supporting the VA's mission to provide specialized treatment options to veterans nationwide.
Quick answers
Who was awarded contract 36C26124N0679?
36C26124N0679 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on May 23, 2024.
How much is contract 36C26124N0679 worth?
The government has obligated $12,581 on 36C26124N0679.
Is contract 36C26124N0679 an order under another contract?
Yes. 36C26124N0679 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0679 competed?
The extent of competition for 36C26124N0679 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award